Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting

Blood Pressure

Volumn 19, Issue 5, 2010, Pages 301-307

  Barrios, Vivencio ^a   Escobar, Carlos ^b   De La Sierra, Alex ^c   Llisterri, José Luis ^d   Gonzlez Segura, Diego ^e  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Primary Care Center Ingeniero Joaquin Benlloch   (Spain)

^e Almirall SA ^*  (Spain)

Author keywords

Clinical; Heart failure; Hypertension; Treatment; Unrecognized; Women

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCREENING TEST; SPAIN;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; RISK FACTORS; SPAIN;

EID: 77957088708     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.488051     Document Type: Article

References (22)

1. Himmelmann A. Hypertension: An important precursor of heart failure. Blood Press. 1999;8:253-260.
2. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562. (Pubitemid 26154241)
3. Barrios V, Peña G, Gonzalez JR, Alegria E, Lozano JV, Llisterri JL, et al. Hypertension and heart failure in primary care and cardiology consultations in Spain. Rev Clin Esp. 2003;203:334-342.
4. Hunt SA, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1-e82.
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;29:933-989.
6. McMurray JJ, Stewart S. Heart failure. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83:596-602.
7. Muñiz J, Crespo MG, Castro A. Epidemiology of heart failure in Spain and the importance of adhering to clinical practice guidelines. Rev Esp Cardiol. 2006;6:2F - 8F.
8. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137-1146.
9. Lund L, Mancini D. Heart Failure in women. Med Clin North Am. 2004;88:1321-1345.
10. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines in the United States. Circulation. 2005;111:499-510.
11. Barrios V, Escobar C, Bertomeu V, Murga N, de Pablo C, Calder ó n A. Sex differences in the hypertensive population with chronic ischemic heart disease. J Clin Hypertens (Greenwich). 2008;10:779-786.
12. Murga N, Pedreira M, Maz ón P, Alonso A. Current topics (2005) in clinical cardiology: Cardiovascular disease in women. Rev Esp Cardiol. 2006;59 Supl 1:99-104.
13. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007; 115:1481-1501. (Pubitemid 46648385)
14. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 1971;285:1441-1446.
15. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21:1011-1053.
16. Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: Data for the period 1987 - 2003 from the Swedish Hospital Discharge Registry. Eur Heart J. 2009;30:671-678.
17. Frazier CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007;49:1450-1458.
18. Redondo-Bermejo B, Pascual-Figal DA, Hurtado-Martínez JA, Peñafiel-Verd ú P, Saura-Esp ín D, Garrido-Bravo IP, et al. Influence of gender on the clinical characteristics and prognosis of patients hospitalized for heart failure. Rev Esp Cardiol. 2007;60:1135-1143. (Pubitemid 350294343)
19. Britton KA, Gaziano JM, Djoussé L. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail. 2009;11:1129-1134.
20. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355: 260-269. (Pubitemid 44088349)
21. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.
22. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467.